This week on the Culture Gabfest, Stephen Metcalf, Dana Stevens, and Julia Turner discuss the Netflix film My Octopus Teacher. Next, they chat about the legacy and ending of Keeping Up With the Kardashians (check out the Gabfest’s 2011 conversation about the Kardashians here). Finally, the panel is joined by Slate staff writer Aaron Mak to analyze the latest episode of Reply All on QAnon.

On Slate Plus, the hosts discuss how they try to balance work and family.

Slate Plus members get a bonus segment on the Culture Gabfest each episode, and access to exclusive shows like Dana Stevens’ classic movies podcast Flashback. Sign up now to listen and support our work.

Outro Music: The Red Light Special by Matt Large

Podcast production by Cameron Drews. Production assistance by Rachael Allen.

Hosted on Acast. See acast.com/privacy for more information.

Donald Trump has spent the last four years refusing to release his tax returns. When the New York Times published 20 years worth of them, it revealed a possible reason why. The president’s balance sheet listed huge losses, which he used to dramatically cut down what he owed in taxes. 

Were these the dealings of a savvy businessman, or an unscrupulous swindler? And what does it mean for the election to have a candidate who still has a stake in their business and an alarming amount of debt?

Guest: Andrea Bernstein, co-host of the Trump, Inc. podcast and the author of “American Oligarchs: the Kushners, the Trumps and the Marriage of Money and Power.”

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

Podcast production by Mary Wilson, Jayson De Leon, Danielle Hewitt, and Elena Schwartz.

Hosted on Acast. See acast.com/privacy for more information.

When you settle in to watch the Presidential debate tonight, maybe you’ll be listening to hear how Trump talks about the New York Times story regarding his tax returns. Maybe you’ll want to hear what Joe Biden has to say about the Supreme Court. 

But Rick Hasen, an election law expert at UC-Irvine, says he’ll be listening for something else: how the two candidates talk about the integrity of this election.

Guest: Rick Hasen, an election law expert at UC-Irvine and the author of “Election Meltdown: Dirty Tricks, Distrust, and the Threat to American Democracy.”

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

Hosted on Acast. See acast.com/privacy for more information.

Joel Anderson, Stefan Fatsis, and Josh Levin talk about the NBA Finals matchup between the Heat and the Lakers. They also discuss why they’re watching college football and life inside the NHL bubble. Finally, they’re joined by Father Edwin Leahy to discuss the documentary series Benedict Men.

NBA (02:11): How did the Heat rebuild after LeBron left? And do they have a chance against LeBron now?

College football and the NHL (16:22): Why we can’t shake an immoral sport, and what we’ve learned about the pro hockey postseason.

Benedict Men (33:44): Why does a critic of big-time high school basketball preside over one of the nation’s top basketball programs?

Afterball (47:54): Stefan on Brian’s Song, which has not aged well.

Hosted on Acast. See acast.com/privacy for more information.

Over the weekend, President Trump announced that Amy Coney Barrett would be his pick to replace Justice Ruth Bader Ginsburg on the Supreme Court. What can we glean from her biography and past rulings about what kind of Justice she would be? 

Guest: Mark Joseph Stern, covers the courts and the law for Slate.

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

Hosted on Acast. See acast.com/privacy for more information.

Dahlia Lithwick is joined by the Nation’s justice correspondent Elie Mystal and Slate’s Mark Joseph Stern for some hard truths about the future of the Supreme Court and what, if anything, Democrats can do about it. 

In this week’s Slate Plus segment, Mark sticks around to delve into the worrying news coming out of Pennsylvania and other adventures in pre-election litigation. 

Sign up for Slate Plus now to listen and support our show.

Podcast production by Sara Burningham.

Slate’s Amicus on Facebook https://www.facebook.com/amicuspodcast/

Hosted on Acast. See acast.com/privacy for more information.

Felix Salmon, Emily Peck, and Anna Szymanski discuss the FinCEN files, Buzzfeed News and ICIJ’s big report on money laundering and banks, the economic stress of getting COVID-19, and the big money in exercise, 

In the Slate Plus segment: COVID-19 thoughts.

Email: [email protected]

Podcast production by Jessamine Molli.

Twitter: @felixsalmon, @Three_Guineas, @EmilyRPeck

Hosted on Acast. See acast.com/privacy for more information.

"Once you're done with football, you're done with football."

Look out for more in our Game Changer series, about the ways athletes' lives and livelihoods have been upended by COVID-19, next week. 

Follow our show on Twitter, Facebook and Instagram @deathsexmoney. Got a story to share? Email us any time at [email protected]. Support our work at deathsexmoney.org/donate.

And stay in touch with us! Sign up for our newsletter and we'll keep you up to date about what's happening behind the scenes at Death, Sex & Money. Plus, we'll send you audio recommendations, letters from our inbox and a note from Anna. Join the Death, Sex & Money community and subscribe today.

Hosted on Acast. See acast.com/privacy for more information.

As of Sept. 24, there are 42 vaccines in clinical trials on humans. At least 92 others are being developed but have not yet gone to trial. For months, the world has tracked the progression of these vaccines closely, with the expectation that once one arrives on the market, we can finally start to go back to normal. But, is that true? Does the world really look much different with an effective vaccine?

Guest: Dr. Paul Offit, professor of pediatrics at the Children's Hospital of Philadelphia.

Host

Celeste Headlee

Hosted on Acast. See acast.com/privacy for more information.

As of Sept. 24, there are 42 vaccines in clinical trials on humans. At least 92 others are being developed but have not yet gone to trial. For months, the world has tracked the progression of these vaccines closely, with the expectation that once one arrives on the market, we can finally start to go back to normal. But, is that true? Does the world really look much different with an effective vaccine?

Guest: Dr. Paul Offit, professor of pediatrics at the Children's Hospital of Philadelphia.

Host

Celeste Headlee

Hosted on Acast. See acast.com/privacy for more information.